Webinar: Introducing neutralizing monoclonal antibody treatment for patients with COVID-19
September 29, 2021
A new treatment (Ronapreve) which is a neutralising monoclonal antibody treatment will soon be available for inpatients.
A webinar will be taking place today (Wednesday 29 September) from 1.30pm – 2.30pm where colleagues can learn more about the treatment rationale, pathways and prescribing information.
Panel members joining the webinar will include colleagues from the Medical Director’s Office, Pharmacy and Clinical Advisory Group.
Click here to join the webinar.
See below for treatment pathway and add on request process: